Comparar métodos

	EORTC QLQ-CX24: Qualidade de Vida em Câncer de Colo de Útero	EORTC QLQ-BR23: Qualidade de Vida em Câncer de Mama
Área	Oncologia	Oncologia
Família	Process / pipeline	Process / pipeline
Ano de origem	2006	1996
Autor original	Greimel, E. R., et al. (EORTC Quality of Life Group)	Sprangers, M. A., et al. (EORTC Quality of Life Group)
Tipo	Self-report questionnaire	Self-report questionnaire
Fonte seminal	Greimel, E. R., Kuljanic Vlasic, K., Zwahlen, D., Rand, K., Heitz, U., Havsteen, H., et al. (2006). The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Acta Oncol, 45(3), 344–351.	Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768.
Outros nomes	QLQ-CX24	QLQ-BR23
Relacionados	5	5
Resumo	The EORTC QLQ-CX24 is a 24-item cervical-cancer-specific module designed to complement the EORTC QLQ-C30 core questionnaire. Developed by Greimel et al. in 2006, it measures sexual/vaginal function, body image, lymphedema, neuropathy, and gastrointestinal symptoms specific to cervical cancer and its treatments. It is the standard cervical cancer-specific QoL instrument in international oncology research.	The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research.